Imagine being able to slow down the ageing process – it’s a dream that’s becoming a lucrative reality for a growing industry. But here’s where it gets controversial: as people shell out up to $1,300 for longevity treatments, a stark divide emerges between what science actually supports and what consumers are paying for. Is this the future of ageing, or just an expensive illusion?
The longevity industry is booming, promising to turn back the clock—or at least slow it down. Clinics like Biograph, with locations in New York City and San Francisco, offer exhaustive assessments that can last up to six hours. During this time, over 1,000 data points are collected from more than 30 advanced diagnostics, including proprietary MRI and CT scans, body composition analysis, VO2 max testing, and comprehensive bloodwork. Clients spend the day in a private suite, decompressing between tests and reviewing their results. Weeks later, they receive a personalized health risk profile that synthesizes all this data. But is this level of detail truly necessary, or just a luxury for the wealthy?
This is just the tip of the iceberg in a rapidly expanding industry that treats ageing as a manageable—and, for a price, reversible—process. While the global wellness economy has exploded in recent years, longevity is emerging as one of its fastest-growing segments. From Meraki Wellness, a 16,000-sq-ft destination opening in Grand Cayman, to Le Barthélemy Hotel in St Barth, which pairs biological age testing with seaside mindfulness sessions, the options are endless. In Switzerland, Clinique La Prairie offers a 'Life Reset' program focused on mental longevity, combining diagnostics with personalized nutrition, neurostimulation, sleep optimization, and stress-resilience therapies. But here’s the kicker: these treatments often come with a hefty price tag, raising questions about who can truly afford to chase eternal youth.
And this is the part most people miss: the longevity business isn’t just confined to standalone clinics. It’s infiltrating luxury hospitality, where hotels are rebranding wellness protocols as a core part of the travel experience. Take the Four Seasons Los Angeles at Beverly Hills, where a $1,000 'Flight Check' protocol addresses the physiological toll of air travel. Developed in partnership with Immortelle Integrative Health, this 60-minute treatment includes IV therapy, laser-based immune fortification, light therapy for brain function, and thermotherapy for circulation and tissue repair. Add-ons like genetic analysis, gut health testing, and stem cell therapy are available for those willing to pay extra.
Evan Pinchuk, CEO of Immortelle, explains that the program was inspired by observing hotel guests arriving in physiological distress. '90% of our customers come by plane,' he notes. But is this level of intervention truly necessary for recovery, or just a luxury for the elite? Jessica Jacobson, Immortelle’s co-founder, draws parallels between flight recovery and post-surgery recovery, arguing that flying creates a 'perfect storm of immune suppression' that people often overlook. But is this a real health concern, or just a marketing tactic?
What does the science say? Experts like Deborah Kado, a professor of medicine at Stanford, are cautious. While some wellness biomarkers may provide useful information, she emphasizes that the outcomes are far from guaranteed. 'The key word is 'perhaps',' she says. For interventions like red light therapy, contrast therapy, infrared saunas, and cold plunges, the evidence is thin. Assuming that treatments effective in animals will work in humans is just that—an assumption, not a proven fact.
Andrea LaCroix, a professor at UC San Diego, is even more direct: 'There’s an absence of clinical trial data showing that any interventions extend healthy longevity in humans. These treatments should be seen as self-experimentation at your own risk.' But if the science isn’t there, why are people still paying thousands of dollars?
The price of entry varies wildly, from $200 for a wellness screening to $1,300 for a 45-minute 'cellular repair' session. Comprehensive annual programs can cost several thousand dollars. The central pitch is always the same: advanced diagnostics and targeted interventions can help you live longer and better. But does the science support these claims? Michael Doney, executive medical director of Biograph, distinguishes between 'true diagnostic clinics' and the broader wellness category. At Biograph, longevity means extending both healthspan and lifespan by identifying and addressing risks early. But is this approach accessible to everyone, or just the privileged few?
Frank Lipman, an integrative medicine physician, offers a pragmatic view. 'Science mainly supports the importance of a healthy diet, time-restricted eating, quality sleep, regular exercise, stress management, and having purpose in life,' he says. While some cutting-edge treatments may lack scientific validation, he acknowledges that science often lags behind innovation. But are consumers being misled by promises that science can’t yet deliver?
Shula Clarke, co-founder of Meraki Wellness, emphasizes that her destination focuses on holistic wellbeing rather than clinical diagnosis. 'We’re not a medical setting,' she says. But as the line between wellness and medicine blurs, who’s holding these companies accountable?
Women’s health is another dimension of this industry, with menopause-focused offerings priced at several thousand dollars. Jessica Shepherd, a women’s health physician, sees both promise and risk. While women are demanding better care for menopause, she warns against the notion that it’s something to be 'fixed' with expensive treatments. 'Menopause is a transition to be supported, not a problem to be solved,' she says. But are women being pressured into spending thousands on treatments they may not need?
The longevity industry’s popularity raises critical questions about health equity. Deborah Kado points out that a two-tier ageing system already exists in the U.S., where those with fewer resources often forgo preventative care. 'You don’t have to be super wealthy to enjoy healthy longevity,' she says, citing examples of centenarians who never used luxury services. But as the industry grows, who will be left behind?
Melanie Goldey, CEO of Tally Health, calls for industry-wide accountability. 'Longevity becomes problematic when companies charge large sums while overstating what science can deliver,' she says. 'Fair pricing means being transparent about what’s supported by research and what remains unknown.'
So, what do you think? Is the longevity industry a groundbreaking advancement, or just another way for the wealthy to buy an illusion of youth? Are these treatments worth the cost, or is the science still too uncertain? Let us know in the comments—we want to hear your thoughts!
